Background: Gastrointestinal (GI) dysmotility and autonomic neuropathy are common problems among diabetics with largely unknown aetiology. Many peptides are involved in the autonomic nervous system regulating the GI tract. The aim of this study was to examine if concentrations of oxytocin, cholecystokinin (CCK), gastrin and vasopressin in plasma differ between diabetics with normal function and dysfunction in GI motility. Methods: Nineteen patients with symptoms from the GI tract who had been examined with gastric emptying scintigraphy, oesophageal manometry, and deep-breathing test were included. They further received a fat-rich meal, after which blood samples were collected and plasma frozen until analysed for hormonal concentrations. Res...
BACKGROUND: To differentiate gastric motility and sensation between type II diabetic patients and co...
Gastric emptying is frequently abnormal in patients with long-standing type 1 and type 2 diabetes me...
Recent data from the Diabetes Control and Complications Trial/Epidemiology of Diabetic Interventions...
Gastrointestinal dysmotility is common, particularly in patients with diabetes mellitus. The aim of ...
Aims/hypothesis Among diabetic patients, glucose homeostasis may be affected by abnormal gastrointes...
BACKGROUND: Gastrointestinal complications in diabetes may affect glucose and endocrine homeostasis....
AIM: Dysmotility in the upper gastro intestinal (GI) tract are common problems in diabetics. Many pe...
The human stomach is a complex organ with sophisticated function. – The control of delivery of nutri...
Major cause of morbidity in diabetic patients is relatively due to disturbances in upper gastrointes...
BackgroundNumerous hormones secreted by the gut, during both the fasted state and in response to a m...
AIM: To investigate the relationship between gastric dysmotility, gastrointestinal hormone abnormali...
A very common complication in diabetes mellitus is abnormal gastrointestinal mobility. In diabetic p...
Recently, diabetic gastroparesis (DGP) has received much attention as its prevalence is increasing i...
Background. To differentiate gastric motility and sensation between type II diabetic patients and co...
Gastrointestinal autonomic neuropathy represents an important and diverse, but poorly appreciated, m...
BACKGROUND: To differentiate gastric motility and sensation between type II diabetic patients and co...
Gastric emptying is frequently abnormal in patients with long-standing type 1 and type 2 diabetes me...
Recent data from the Diabetes Control and Complications Trial/Epidemiology of Diabetic Interventions...
Gastrointestinal dysmotility is common, particularly in patients with diabetes mellitus. The aim of ...
Aims/hypothesis Among diabetic patients, glucose homeostasis may be affected by abnormal gastrointes...
BACKGROUND: Gastrointestinal complications in diabetes may affect glucose and endocrine homeostasis....
AIM: Dysmotility in the upper gastro intestinal (GI) tract are common problems in diabetics. Many pe...
The human stomach is a complex organ with sophisticated function. – The control of delivery of nutri...
Major cause of morbidity in diabetic patients is relatively due to disturbances in upper gastrointes...
BackgroundNumerous hormones secreted by the gut, during both the fasted state and in response to a m...
AIM: To investigate the relationship between gastric dysmotility, gastrointestinal hormone abnormali...
A very common complication in diabetes mellitus is abnormal gastrointestinal mobility. In diabetic p...
Recently, diabetic gastroparesis (DGP) has received much attention as its prevalence is increasing i...
Background. To differentiate gastric motility and sensation between type II diabetic patients and co...
Gastrointestinal autonomic neuropathy represents an important and diverse, but poorly appreciated, m...
BACKGROUND: To differentiate gastric motility and sensation between type II diabetic patients and co...
Gastric emptying is frequently abnormal in patients with long-standing type 1 and type 2 diabetes me...
Recent data from the Diabetes Control and Complications Trial/Epidemiology of Diabetic Interventions...